What's breaking now, across thousands of outlets.
Researchers say the oral drug LM11A-31 slowed the decline of brain-network function in a small trial, pointing to a potential broader strategy for treating Alzheimer’s.
We haven't written up this one. Inc. has the full story — the link below goes straight to it.
(MedPage Today) -- The monoclonal antibody nirsevimab (Beyfortus) consistently performed well against respiratory syncytial virus (RSV)-related hospitalization during infants' first year after receipt but without a benefit for other hospitalizations...
The Ghana Adventist Health Services of the Seventh-day Adventist (SDA) Church has expressed its commitment to partner the government to complete some Agenda 111 hospital projects across the country.
As gambling becomes more accessible to college students, a statewide study of Mississippi's public universities found gambling problems frequently occur alongside depression, anxiety and substance…
Heart Fit Clinic will be on Talk To The Experts this weekend – Saturday, August 15th at 10:00AM! There is never a bad time to examine just where your health truly is.
